Immucor

Sirona Genomics was spun out of the Stanford Genome Technology Center (SGTC) at Stanford University with a focus on developing next generation sequencing typing applications specifically for the HLA System. Based in Mountain View, CA, the company was founded by Ron Davis, Ph.D., Director of the SGTC and Professor of Biochemistry and Genetics at Stanford University; Mark Davis, Ph.D., Director of Stanford Institute for Immunity, Transplantation and Infection, and Professor of Microbiology and Immunology at Stanford University; Michael Mindrinos, Ph.D., former Associate Director of the SGTC; Marcelo Fernández-Viña, Ph.D., Professor for the Department of Pathology at Stanford University Medical School, co-Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at Stanford University; Sujatha Krishnakumar, former Life Science Research Associate at SGTC; and Chunlin Wang, former Senior Research Scientist at SGTC.

Durham, NC-based Sentilus was founded in 2012 and is developing an inkjet-printed antibody microarray-based technology called Femtoarrays for use in in vitro diagnostics, including transfusion diagnostics.

Organ-i is a biotech diagnostic company specializing in non-invasive tests for monitoring renal health, particularly for transplant recipients. By leveraging a proprietary, clinically validated gene-based biomarker, Organ-i significantly enhances the ability of clinicians to diagnose kidney rejection and monitor the health of transplanted kidneys. The company holds an exclusive license for its patented technology from Stanford University and is commencing commercial operations in Northern California. Additionally, Organ-i is developing a pipeline of molecular assays aimed at post-transplant rejection monitoring and promoting allograft tolerance, thereby providing valuable treatment insights for both physicians and their patients.